Rönninge, Sweden

Göran Isacsson

This inventor holds 2 USPTO granted patents. Top assignees: Astra Ab, Astrazeneca Ab. Active years: 2002-2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Göran Isacsson. Retrieved from https://idiyas.com/inventor/gandoumlran-isacsson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002-2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Göran Isacsson: Innovator in Pain Management

Introduction

Göran Isacsson is a notable inventor based in Rönninge, Sweden. He has made significant contributions to the field of pain management, particularly through his innovative use of ropivacaine. With a total of 2 patents to his name, Isacsson's work has the potential to impact the treatment of musculoskeletal pain.

Latest Patents

Isacsson's latest patents focus on the intramuscular use of ropivacaine for the manufacture of a medicament aimed at treating musculoskeletal pain. This includes specific applications for myofascial pain and tendinitis, showcasing his commitment to improving patient care in pain management.

Career Highlights

Throughout his career, Isacsson has worked with prominent companies such as Astra AB and AstraZeneca AB. His experience in these organizations has undoubtedly contributed to his expertise and innovative approach in the medical field.

Collaborations

Isacsson has collaborated with various professionals, including his coworker Dag Selander. These partnerships have likely enriched his work and expanded the scope of his inventions.

Conclusion

Göran Isacsson's contributions to pain management through his patents and collaborations highlight his role as an influential inventor in the medical field. His work continues to pave the way for advancements in treating musculoskeletal pain.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…